<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47656B2A-AD76-4F65-AC28-26EA91F155EB"><gtr:id>47656B2A-AD76-4F65-AC28-26EA91F155EB</gtr:id><gtr:name>University of Malaga</gtr:name><gtr:address><gtr:line1>Campus de Teatinos</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47656B2A-AD76-4F65-AC28-26EA91F155EB"><gtr:id>47656B2A-AD76-4F65-AC28-26EA91F155EB</gtr:id><gtr:name>University of Malaga</gtr:name><gtr:address><gtr:line1>Campus de Teatinos</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/137615F8-119D-4240-8D2C-4094BCA65943"><gtr:id>137615F8-119D-4240-8D2C-4094BCA65943</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>Dixon</gtr:otherNames><gtr:surname>Hastie</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127527180"><gtr:id>E9E5A01B-42A7-42BE-9A1C-E9FCAB49BE57</gtr:id><gtr:title>Cancer, Development and the Multifunctional Wilms Tumour Gene, WT1</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127527180</gtr:grantReference><gtr:abstractText>Wilms tumour is a kidney cancer that is quite common in children during the first 5 years of life. It is clearly a remarkable example of cancer arising through the normal processes of development going wrong. In order to understand how the tumour develops with a view to better treatments, we have to understand the processes of normal kidney development and how these go awry on the route to tumorigenesis. We are studying a Wilms tumour predisposition gene, WT1, mutations in which result in Wilms tumour but may also lead to other life-threatening kidney diseases and abnormalities of the sexual organs. We have shown that this gene is vital for normal kidney, testis and ovary development and one of our major goals is to understand how WT1 controls differentiation of these tissues and why disease develops when the gene is mutated. We have shown that WT1 is necessary for cells to divide and to prevent differentiation in certain tissues such as blood vessels of the heart. We propose to dissect WT1s role in these processes and to test the idea that it may play a major role in stem cell maintenance, tissue repair and in adult cancer. We have also shown WT1 is a remarkable example of a single gene encoding multiple proteins that may differentially regulate gene expression both in the nucleus and in the cytoplasm. One of our major goals is to understand these functions and how they control normal development and disease. We are taking a multidisciplinary approach to our work and are trying to set-up novel systems in culture to test the function of WT1 and associated genes.</gtr:abstractText><gtr:technicalSummary>Mutations in the Wilms tumour suppressor gene, WT1, may lead not only to the eponymous childhood kidney cancer, but also to severe glomerular nephropathy and gonadal dysgenesis, including sex reversal. In order to understand the mechanisms underlying these conditions with a view to novel therapies, we must elucidate the roles of WT1 in normal genitourinary development and establish mouse models that mimic the human diseases as closely as possible. Our studies so far indicate that whereas WT1 is essential for terminal differentiation of the kidney nephron, consistent with its role as a tumour suppressor, in other tissues such as heart, great vessels and liver, WT1 appears to play the reverse role, i.e. maintaining vascular and other progenitors in an undifferentiated state. In these cases, we suggest it is necessary to shut off WT1 function for cells to terminally differentiate. Our findings provide a basis for the growing view that WT1 may act as an oncogene in some common adult cancers where it is highly expressed.||We aim to continue to dissect the roles of WT1 in normal kidney development. We are using a conditional WT1 model to dissect roles for WT1 in different stages of nephron development. We have strong data to support a model where in condensing mesenchyme WT1 directly activates WNT4, the essential signalling molecule in the epithelialization of the nephron. We are extending this with analyzing the downstream pathways of WNT4 in this process, and new models (in vitro and in vivo) to understand the role of beta-catenin mutations in Wilms tumors. We re hoping combined all this will help us to develop a mouse model for Wilms tumors. We are also testing the hypothesis that WT1 maintains progenitor cells in an undifferentiated state in the heart, liver and some specific neurons. Furthermore, we will use cellular and whole animal models to rigorously test the hypothesis that WT1 is an oncogene in adult cancers and to dissect the mechanisms and pathways involved. In this context a major development is the role we have identified for WT1 in regulating epithelial to mesenchymal transitions by direct regulation of Snail.||In order to understand the roles of WT1 in development and disease, we must understand its function at the biochemical and cellular levels. The WT1 gene encodes multiple protein isoforms, each including 4 C2H2 zinc fingers. There is a considerable body of evidence that WT1 acts as a transcription factor. However, work mainly from this group suggests that some WT1 isoforms regulate gene expression at the post-transcriptional level. We propose to use a variety of approaches to identify target genes and RNAs directly regulated by WT1 in the nucleus and cytoplasm and will dissect the function of different isoforms in post-transcriptional processes.||Parts of the programme on kidney development in particular can now be placed in a broader context as they have strong links with the EU FP6 programme, EUREGENE, and with the NIDDK Genitourinary Atlas programme, PI Duncan Davidson. With our EUREGENE colleagues, we will be exploring new approaches to studying genetic pathways underlying nephrogenesis and to model kidney anatomy in 3D with the help of OPT. The ultimate aim is to build a 4D genitourinary atlas and database which can be used to formulate new hypotheses and to facilitate translational research.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1984-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5175172</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malaga</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>The role of WT1 in mesothelial and cardiovascular development.</gtr:description><gtr:id>3AA91E7C-7602-4E13-80BC-2116FD45172C</gtr:id><gtr:impact>20023660</gtr:impact><gtr:outcomeId>1E96AA0571B-1</gtr:outcomeId><gtr:partnerContribution>Professor Ramon Munoz Chapuli, our collaborator, has brought considerable intellectual contribution to the project. He has also carried out a great deal of skilled embryological, anatomical and histopathological analysis.</gtr:partnerContribution><gtr:piContribution>My group has demonstrated the mechanisms controlling the formation of cardiovascular progenitor cells, using studies in whole animals, at the cellular and molecular levels.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>The Max Delbr?ck Center for Molecular Medicine (MDC)</gtr:department><gtr:description>EuReGene</gtr:description><gtr:id>64D25772-FB77-4D13-8E1C-E198ADE16F44</gtr:id><gtr:impact>19014667. Several additional papers are in preparation</gtr:impact><gtr:outcomeId>B4B63B004AF-1</gtr:outcomeId><gtr:partnerContribution>EuReGene is an FP6 Integrated Project coordinated by Professor Thomas Willnow. Its goal is to dissect the mechanisms underlying kidney development and physiology and to create a kidney atlas. EuReGene involves partners in 8 different European countries. The different partners bring different and complementary skills to the project.</gtr:partnerContribution><gtr:piContribution>My team has contributed intellectually to the Consortium; we have developed new imaging tools for analysing the kidney; we have developed new animal models and cell lines. Finally we have ellucidated some of the molecular pathways controlling kidney development. We have also develooped new DNA vectors for rapid genetic manipulation in mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Population Health Sciences</gtr:department><gtr:description>EuroSpan</gtr:description><gtr:id>847E2C60-795E-4679-89F0-9756DEB12154</gtr:id><gtr:impact>18952825 19060911 19798445 19851299 19387472 20066028 2022955 20383146</gtr:impact><gtr:outcomeId>00631996B2F-1</gtr:outcomeId><gtr:partnerContribution>This is an FP6 funded STREP which involves collaborators in 4 different European Centres, Croatia, the Netherlands, Italy and Scotland. Our collaborators, like us, gathered very large amounts of data on human traits relevant for disease in thousands of individuals. All these individuals were genotyped and using this information we were able to identify numerous genetic loci regulating these traits.</gtr:partnerContribution><gtr:piContribution>Our contributions are as discussed above.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5827</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission Fellowship</gtr:description><gtr:end>2007-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7C0BD32F-95CD-4FD8-919F-F7F6BA33D804</gtr:id><gtr:outcomeId>UPbMe9evUyW0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167009</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Research Grant</gtr:description><gtr:end>2010-05-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>F8083679-D095-4B1B-9522-1F791EF7CBA7</gtr:id><gtr:outcomeId>1BD0EA10AC50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>143711</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/Beit Fellowship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D4847B31-FD47-4661-AF8F-627C80CA6900</gtr:id><gtr:outcomeId>YTPxwaASS7m0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149859</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research Fund</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>FAA99F97-B442-4FC6-BA02-58A83AF2314B</gtr:id><gtr:outcomeId>aNRZK8PyocW0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98825</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Project Grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>829BC7B7-B5BE-4A5C-840B-1FEAEB53D52D</gtr:id><gtr:outcomeId>01B93D223380</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>428336</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>E432B931-EB69-4A1A-80DA-2B47881EF58A</gtr:id><gtr:outcomeId>Tf41yukiyt90</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>108046</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Incoming Fellowship</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>8C96BD03-0190-44F3-9004-ED88D891331F</gtr:id><gtr:outcomeId>9B915245D290</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218491</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr E.G.J. Olsen Charitable Fund</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Dr E G J Olsen Charitable Trust</gtr:fundingOrg><gtr:id>03B49330-68F8-4B7B-994D-5E7D7D301899</gtr:id><gtr:outcomeId>6FDE1F13EBC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>119981</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D1EEC91F-F305-40B0-82B5-C388DD2F6ABF</gtr:id><gtr:outcomeId>EZkH2XAnDkJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>338750</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU Funded STREP</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>4F838C4A-1E51-45B6-A73C-933096393521</gtr:id><gtr:outcomeId>2E986937CF40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155791</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Fellowship</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>7DF5124F-B92E-4C09-925A-E78D876F837F</gtr:id><gtr:outcomeId>746D00CDD090</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New mouse fetal epicardial cell lines.</gtr:description><gtr:id>664B88CD-9FAF-467C-9D57-9D9952D1101C</gtr:id><gtr:impact>New understanding of cardiovascular development. Martinez-Estrada, Nature Genetics, in press</gtr:impact><gtr:outcomeId>93F38B2F879</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>COOMEC</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new DNA vector and methodology for the rapid manipulation of specific genes in embryonic stem cells.</gtr:description><gtr:id>A75084D3-B889-4D4F-9773-C6F64A1F5867</gtr:id><gtr:impact>This technology has allowed the production of numerous mouse lines which have given significant insights into developmental or disease processes. 19014667</gtr:impact><gtr:outcomeId>0C2DC6833D4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rosa-Dest</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have dissected the mechanisms by which cardiovascular progenitor cells are formed and shown that the process of EMT is essential for the formation of these progenitors.</gtr:description><gtr:id>EB72E32E-E40A-4A28-911F-CC70B6D559F8</gtr:id><gtr:impact>Marteinz-Esstrada, Nature Genetics (in press)</gtr:impact><gtr:outcomeId>D44709D7177</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cardiovascular progenitor cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B9DDD7E-F9FB-4DD3-BBF9-6A5A88ED8B43</gtr:id><gtr:title>Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c53ecc084700b3d6259f7ae9e904affb"><gtr:id>c53ecc084700b3d6259f7ae9e904affb</gtr:id><gtr:otherNames>Guadix JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>LFdwoUhQK64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3331B5B2-223F-45CF-9568-6CD0C43ECFD7</gtr:id><gtr:title>WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bbfee6ff1f80956ad25da722cca88f"><gtr:id>a6bbfee6ff1f80956ad25da722cca88f</gtr:id><gtr:otherNames>Suri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>B34F55993E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96F5521E-C8F6-476C-9F07-BE11FE51E8C6</gtr:id><gtr:title>Actin: a novel interaction partner of WT1 influencing its cell dynamic properties.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8fb4eb396093a852f5a3ad12b122bc"><gtr:id>6d8fb4eb396093a852f5a3ad12b122bc</gtr:id><gtr:otherNames>Dudnakova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>Zd9BtGRjD9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6108584-91DF-4548-BBCD-2980951CF793</gtr:id><gtr:title>Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/062f82bc0b109e96ec3369720e5df3f7"><gtr:id>062f82bc0b109e96ec3369720e5df3f7</gtr:id><gtr:otherNames>Mart?nez-Estrada OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>8FB4A9AC190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D396CCBE-5197-4437-94C6-E4324602AF8B</gtr:id><gtr:title>Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e5e0b8b41e59b2ff20ed2799fddfb84"><gtr:id>7e5e0b8b41e59b2ff20ed2799fddfb84</gtr:id><gtr:otherNames>Chau YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16455_25_22216009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E2E3B29-637F-42A5-B026-14DAD3832025</gtr:id><gtr:title>Genetics of disease.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d028a57d1f2e06b3f769e88283e0bb6d"><gtr:id>d028a57d1f2e06b3f769e88283e0bb6d</gtr:id><gtr:otherNames>Hastie N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>D2C5D92538A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93630842-AF36-40DA-88F9-445DB40F198B</gtr:id><gtr:title>Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef3aaa796e16082423426a2751795a5"><gtr:id>aef3aaa796e16082423426a2751795a5</gtr:id><gtr:otherNames>Ijpenberg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>CA4A2854C49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3763D54E-5B07-4493-B224-0FB56F1D8FA5</gtr:id><gtr:title>Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fb8cc5be24acbc477877032916faaa"><gtr:id>89fb8cc5be24acbc477877032916faaa</gtr:id><gtr:otherNames>Benko S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>473DB3C5EE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51A36A71-7B9C-4384-98B4-FFF6C62EC652</gtr:id><gtr:title>Modification and amplification of yeast artificial chromosomes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24573e89ca5916a273053264a687b6b7"><gtr:id>24573e89ca5916a273053264a687b6b7</gtr:id><gtr:otherNames>Shen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>EA43013BA8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8285A6EC-C2A3-44CD-897B-9D57A310180C</gtr:id><gtr:title>WT1 the oncogene: a tale of death and HtrA.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d902ab094c117efd18e7a367f41544f"><gtr:id>2d902ab094c117efd18e7a367f41544f</gtr:id><gtr:otherNames>Essafi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>CRgsrUDrddx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>377AAF9E-9209-45D0-94ED-804443794F15</gtr:id><gtr:title>The many facets of the Wilms' tumour gene, WT1.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09120cfed3e1705c5ff0a23a581ced62"><gtr:id>09120cfed3e1705c5ff0a23a581ced62</gtr:id><gtr:otherNames>Hohenstein P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5223F76DDE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750F0B42-2524-4B75-ADB2-C29E6F375A8D</gtr:id><gtr:title>A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0e07ccfd98f153fa18c27c0bf44e6ce"><gtr:id>f0e07ccfd98f153fa18c27c0bf44e6ce</gtr:id><gtr:otherNames>Ratelade J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>A0B17902D70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87C92B71-43BA-4A4B-A5CA-90FC854CE1F1</gtr:id><gtr:title>ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ba45b9493c0e6e8854b203a1b6134f3"><gtr:id>2ba45b9493c0e6e8854b203a1b6134f3</gtr:id><gtr:otherNames>Veikkolainen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>ogy221Xr1u3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E97E97ED-52CD-4875-AC4D-5A342EDB3F01</gtr:id><gtr:title>Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94b5acdcc1ba098df4ff0488bb13828b"><gtr:id>94b5acdcc1ba098df4ff0488bb13828b</gtr:id><gtr:otherNames>Berry R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>jDih4HrpRUP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8468C5B-3C04-4C9E-B5CC-49AF60D591C8</gtr:id><gtr:title>Spleen versus pancreas: strict control of organ interrelationship revealed by analyses of Bapx1-/- mice.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef067df7a6ea3455db2dc0850756a96"><gtr:id>8ef067df7a6ea3455db2dc0850756a96</gtr:id><gtr:otherNames>Asayesh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>2814C115EBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B28703BE-F188-4620-88A1-A774B7440D82</gtr:id><gtr:title>Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/281e8ccd9dac9521ceadfbc748fd53c9"><gtr:id>281e8ccd9dac9521ceadfbc748fd53c9</gtr:id><gtr:otherNames>Jennings KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>BCD9ADFD4CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE89A2EE-A851-46E1-9D1C-6178EF790ED3</gtr:id><gtr:title>hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dacfb6034ad0556dd4f0f00e37c3672f"><gtr:id>dacfb6034ad0556dd4f0f00e37c3672f</gtr:id><gtr:otherNames>Spraggon L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>A3CC5EF66CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AE154EC-5C79-488E-B262-C80F128F277B</gtr:id><gtr:title>High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi.</gtr:title><gtr:parentPublicationTitle>PathoGenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09120cfed3e1705c5ff0a23a581ced62"><gtr:id>09120cfed3e1705c5ff0a23a581ced62</gtr:id><gtr:otherNames>Hohenstein P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1755-8417</gtr:issn><gtr:outcomeId>841163E2667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AED73B0-382F-49C2-A1D2-558287B39D12</gtr:id><gtr:title>Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e5e0b8b41e59b2ff20ed2799fddfb84"><gtr:id>7e5e0b8b41e59b2ff20ed2799fddfb84</gtr:id><gtr:otherNames>Chau YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>54183c34ddbfd5.60538289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDBCD487-6A03-4C10-B6E2-3629C6C96CC4</gtr:id><gtr:title>Calcium/NFAT signalling promotes early nephrogenesis.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bca845ac662b1998c0fd3a375f05db45"><gtr:id>bca845ac662b1998c0fd3a375f05db45</gtr:id><gtr:otherNames>Burn SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>VwKPsSfJwBW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F04F50D5-550E-4464-826E-92EC29C1E28F</gtr:id><gtr:title>A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d902ab094c117efd18e7a367f41544f"><gtr:id>2d902ab094c117efd18e7a367f41544f</gtr:id><gtr:otherNames>Essafi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>LEVJfa9YrgA</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127527180</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>